title: Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.
authors.affiliation: Department of Interventional Radiology, Stanford University Medical Center, CA 94305, USA. csemba@stanford.edu
authors.forename: C P
authors.initials: CP
authors.lastname: Semba
authors.forename: C W
authors.initials: CW
authors.lastname: Bakal
authors.forename: K A
authors.initials: KA
authors.lastname: Calis
authors.forename: G E
authors.initials: GE
authors.lastname: Grubbs
authors.forename: D W
authors.initials: DW
authors.lastname: Hunter
authors.forename: T A
authors.initials: TA
authors.lastname: Matalon
authors.forename: T P
authors.initials: TP
authors.lastname: Murphy
authors.forename: D C
authors.initials: DC
authors.lastname: Stump
authors.forename: S
authors.initials: S
authors.lastname: Thomas
authors.forename: D L
authors.initials: DL
authors.lastname: Warner
mesh_terms: D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D002406:Catheterization, Peripheral; D006083:Graft Occlusion, Vascular / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000188:drug therapy
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator